Article

Decentration/dislocation one of the most common reasons for foldable IOL explantation

One of the most common reasons for foldable IOL explantation seems to be decentration/dislocation in one- and three-piece silicone and acrylic lenses, followed by glare and optical aberrations, explained Nick Mamalis, MD, professor of ophthalmology, Intermountain Ocular Research Center, John A. Moran Eye Center, University of Utah, Salt Lake City.

One of the most common reasons for foldable IOL explantation seems to be decentration/dislocation in one- and three-piece silicone and acrylic lenses, followed by glare and optical aberrations, explained Nick Mamalis, MD, professor of ophthalmology, Intermountain Ocular Research Center, John A. Moran Eye Center, University of Utah, Salt Lake City.

Removal of hydrophilic acrylic IOLs was most commonly attributed to calcification/opacification, Dr. Mamalis said. He reported on the 2006 results of a survey sent to members of the American Society of Cataract and Refractive Surgery and the European Society of Cataract and Refractive Surgeons.

"The most common complications involving foldable IOLs have changed little over the past 3 years," Dr. Mamalis said.

Apparently, incorrect lens power is not as much of a concern as it had been in the past, he said. Surgeons are better able to determine the correct lens power prior to surgery and/or corneal enhancement procedures have been utilized in patients with residual refractive error.

"Common complications [with foldable lenses] may continue to be avoided by excellent surgical technique, quality manufacturing, careful IOL folding and insertion, and accurate IOL measurements," Dr. Mamalis said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.